165 related articles for article (PubMed ID: 32440913)
1. lncRNA-NRF is a Potential Biomarker of Heart Failure After Acute Myocardial Infarction.
Yan L; Zhang Y; Zhang W; Deng SQ; Ge ZR
J Cardiovasc Transl Res; 2020 Dec; 13(6):1008-1015. PubMed ID: 32440913
[TBL] [Abstract][Full Text] [Related]
2. Circulating LIPCAR is a potential biomarker of heart failure in patients post-acute myocardial infarction.
Yan L; Zhang Y; Wang M; Wang L; Zhang W; Ge ZR
Exp Biol Med (Maywood); 2021 Dec; 246(24):2589-2594. PubMed ID: 34365838
[TBL] [Abstract][Full Text] [Related]
3. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Olivier A; Girerd N; Michel JB; Ketelslegers JM; Fay R; Vincent J; Bramlage P; Pitt B; Zannad F; Rossignol P;
Int J Cardiol; 2017 Aug; 241():344-350. PubMed ID: 28284500
[TBL] [Abstract][Full Text] [Related]
4. Serum Circulating miR-150 is a Predictor of Post-Acute Myocardial Infarction Heart Failure.
Lin X; Zhang S; Huo Z
Int Heart J; 2019 Mar; 60(2):280-286. PubMed ID: 30745540
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
7. Circulating long non-coding RNAs NRON and MHRT as novel predictive biomarkers of heart failure.
Xuan L; Sun L; Zhang Y; Huang Y; Hou Y; Li Q; Guo Y; Feng B; Cui L; Wang X; Wang Z; Tian Y; Yu B; Wang S; Xu C; Zhang M; Du Z; Lu Y; Yang BF
J Cell Mol Med; 2017 Sep; 21(9):1803-1814. PubMed ID: 28296001
[TBL] [Abstract][Full Text] [Related]
8. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction.
Matsumoto S; Sakata Y; Suna S; Nakatani D; Usami M; Hara M; Kitamura T; Hamasaki T; Nanto S; Kawahara Y; Komuro I
Circ Res; 2013 Jul; 113(3):322-6. PubMed ID: 23743335
[TBL] [Abstract][Full Text] [Related]
9. Circulating exosomal long non-coding RNAs in patients with acute myocardial infarction.
Zheng ML; Liu XY; Han RJ; Yuan W; Sun K; Zhong JC; Yang XC
J Cell Mol Med; 2020 Aug; 24(16):9388-9396. PubMed ID: 32649009
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.
McKie PM; Cataliotti A; Lahr BD; Martin FL; Redfield MM; Bailey KR; Rodeheffer RJ; Burnett JC
J Am Coll Cardiol; 2010 May; 55(19):2140-7. PubMed ID: 20447539
[TBL] [Abstract][Full Text] [Related]
11. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs H19, MALAT1 and MIAT as potential novel biomarkers for diagnosis of acute myocardial infarction.
Wang XM; Li XM; Song N; Zhai H; Gao XM; Yang YN
Biomed Pharmacother; 2019 Oct; 118():109208. PubMed ID: 31302423
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.
Raposeiras-Roubín S; Rodiño-Janeiro BK; Paradela-Dobarro B; Grigorian-Shamagian L; García-Acuña JM; Aguiar-Souto P; Jacquet-Hervet M; Reino-Maceiras MV; Alvarez E; González-Juanatey JR
Cardiovasc Diabetol; 2012 Aug; 11():102. PubMed ID: 22909322
[TBL] [Abstract][Full Text] [Related]
15. Correlation between Troponin-I and B-Type Natriuretic Peptide Level in Acute Myocardial Infarction Patients with Heart Failure.
Islam MN; Alam MF; Debnath RC; Aditya GP; Ali MH; Hossain MA; Siddique SR
Mymensingh Med J; 2016 Apr; 25(2):226-31. PubMed ID: 27277352
[TBL] [Abstract][Full Text] [Related]
16. C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study.
Khan SQ; Dhillon O; Struck J; Quinn P; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
Am Heart J; 2007 Oct; 154(4):736-42. PubMed ID: 17893002
[TBL] [Abstract][Full Text] [Related]
17. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
[TBL] [Abstract][Full Text] [Related]
18. Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction.
Gao L; Liu Y; Guo S; Yao R; Wu L; Xiao L; Wang Z; Liu Y; Zhang Y
Cell Physiol Biochem; 2017; 44(4):1497-1508. PubMed ID: 29258067
[TBL] [Abstract][Full Text] [Related]
19. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
